Evidence map›Paper›PMID 25804401›Full record

GuidelineEuropean journal of human genetics : EJHG2016

Guidelines for cytogenetic investigations in tumours.

Rosalind J Hastings, Nick Bown, Maria G Tibiletti, Maria Debiec-Rychter, Roberta Vanni, Blanca Espinet, Nadine van Roy, Paul Roberts, Eva van den Berg-de-Ruiter, Alain Bernheim and 11 more

Abstract readGuideline
In one paragraph

Guideline in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Frontiers in cardiovascular medicine · 2026
    Article
  3. Diagnostics (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. A novel next generation sequencing approach to improve sarcoma diagnosis.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Rosalind J HastingsWomen's Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
Nick BownNorthern Genetics Service, Institute of Genomic Medicine, Central Parkway, Newcastle, UK.
Maria G TibilettiUO Anatomia Patologica, Ospedale di Circolo-Polo Universitario, Varese, Italy.
Maria Debiec-RychterLaboratory for Genetics of Malignant Disorders, Department of Human Genetics, University Hospital Gasthuisberg, UZ Leuven, Leuven, Belgium.
Roberta VanniDepartment of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, Monserrato, Italy.
Blanca EspinetLaboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
Nadine van RoyCentre for Medical Genetics, University Hospital Ghent, Ghent, Belgium.
Paul RobertsCytogenetics Department, St James's Hospital, Leeds, UK.
Eva van den Berg-de-RuiterDepartment of Genetics, University of Groningen, University Medical Centre Groningen, RB Groningen, The Netherlands.
Alain BernheimGénétique des tumeurs (INSERM U985), Laboratoire de Cytogénétique, Pathologie Moléculaire Gustave Roussy, Paris-Villejuif, France.
Jacqueline SchoumansCancer Cytogenetic Unit, Lausanne University Hospital, CHUV, Lausanne, Switzerland.
Steve ChattersHaematology, Cellular and Molecular Diagnostic Service, Great Ormond St Hospital, London, UK.
Zuzana ZemanovaCenter of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Marian Stevens-KroefRadboud University Nijmegen Medical Centre Department of Human Genetics, HB Nijmegen, The Netherlands.
Annet SimonsRadboud University Nijmegen Medical Centre Department of Human Genetics, HB Nijmegen, The Netherlands.
Sverre HeimInstitute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Marta SalidoLaboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
Bauke YlstraDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, MB Amsterdam, The Netherlands.
David R BettsDepartment of Clinical Genetics, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland.
Tumour Best Practice meeting
Eurogentest

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AccreditationBiomarkersBiopsy, Fine-NeedleCytogenetic AnalysisEuropeGene ExpressionHigh-Throughput Nucleotide SequencingHumansIn Situ Hybridization, FluorescenceNeoplasm ProteinsNeoplasmsParaffin EmbeddingResearch DesignSensitivity and SpecificityTissue Array AnalysisTissue FixationBiomarkersNeoplasm Proteins

Identifiers

PMID25804401
PMCPMC4795217

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.